DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer

BACKGROUND: Duke pancreatic mono-clonal antigen type 2 (DUPAN-II) is a famous tumour maker for pancreatic cancer (PC) as well as carbohydrate antigen 19–9 (CA19-9). We evaluated the clinical implications of DUPAN-II levels as a biological indicator for PC during preoperative chemoradiation therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Shinichiro, Takahashi, Hidenori, Akita, Hirofumi, Mukai, Yosuke, Mikamori, Manabu, Asukai, Kei, Yamada, Daisaku, Wada, Hiroshi, Fujii, Yoshiaki, Sugase, Takahito, Yamamoto, Masaaki, Takeoka, Tomohira, Shinno, Naoki, Hara, Hisashi, Kanemura, Takashi, Haraguchi, Naotsugu, Nishimura, Junichi, Matsuda, Chu, Yasui, Masayoshi, Omori, Takeshi, Miyata, Hiroshi, Ohue, Masayuki, Ishikawa, Osamu, Sakon, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850710/
https://www.ncbi.nlm.nih.gov/pubmed/36653747
http://dx.doi.org/10.1186/s12885-023-10512-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850710/
https://www.ncbi.nlm.nih.gov/pubmed/36653747
http://dx.doi.org/10.1186/s12885-023-10512-2

Ejemplares similares